The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Kite/Gilead
Stock and Other Ownership Interests - Gilead Sciences
Product characteristics and pharmacological profile of KTE-X19 in patients (pts) with relapsed/refractory (R/R) mantle cell lymphoma (MCL) in the phase II registrational ZUMA-2 trial.
 
Michael Wang
Stock and Other Ownership Interests - More Health
Honoraria - AstraZeneca; Dava Oncology; Janssen Research & Development; OM Pharmaceutical Industries; Onclive; oncology business review; Peerview; Pharmacyclics; Targeted Oncology
Consulting or Advisory Role - AstraZeneca; AxImmune; Bioinvent; Celgene; Guidepoint Global; Janssen Research & Development; Juno Therapeutics; Kite, a Gilead company; Loxo; More Health; Noble Insights; Pharmacyclics/Janssen; Pulse Biosciences
Research Funding - Acerta Pharma; Amgen; AstraZeneca; BeiGene; Bioinvent; Celgene; Janssen Research & Development; Juno Therapeutics; Kite, a Gilead company; Loxo; Novartis; Oncternal Therapeutics; Pharmacyclics; VelosBio; Verastem
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Dava Oncology; Janssen Research & Development; OM Pharmaceutical Industries
 
John M. Rossi
No Relationships to Disclose
 
Javier Munoz
Honoraria - Kyowa Hakko Kirin; Seagen
Consulting or Advisory Role - Alexion Pharmaceuticals; Bayer; BeiGene; Bristol-Myers Squibb; Celgene; Fosun Kite; Genentech; Gilead Sciences; Innovent Biologics; Janssen; Juno Therapeutics; Kite, a Gilead company; Kyowa Hakko Kirin; Pfizer; Pharmacyclics; Seagen
Speakers' Bureau - Abbvie/Genentech; Acrotech Biopharma; AstraZeneca; Bayer; BeiGene; BeiGene; Celgene; Gilead Sciences; Kite, a Gilead company; Kyowa Hakko Kirin; Pharmacyclics/Janssen; Seagen; Verastem
Research Funding - Celgene; Genentech/Abbvie; Incyte; Kite, a Gilead company; Millennium; Pharmacyclics/Janssen; Portola Pharmaceuticals; Seagen
 
Andre Goy
Employment - Regional Cancer Care Associates
Leadership - COTA
Stock and Other Ownership Interests - COTA
Honoraria - Acerta Pharma; AstraZeneca; Celgene; Kite/Gilead; MJH Healthcare Holdings, LLC; Pharmacyclics/Janssen; Physicans' Education Resource; PracticeUpdate; Xcenda
Consulting or Advisory Role - Acerta Pharma; AstraZeneca; Kite/Gilead; Pharmacyclics/Janssen; Physicans' Education Resource; PracticeUpdate; Xcenda
Research Funding - Acerta Pharma; Genentech; Kite/Gilead; Pharmacyclics/Janssen; Takeda
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - Physicans' Education Resource
Other Relationship - COTA/Celgene
 
Frederick Lundry Locke
Stock and Other Ownership Interests - Cellular Biomedicine Group
Consulting or Advisory Role - Alimera Sciences; Calibr; Celgene; Cellular Biomedicine Group; EcoR1 Capital; GammaDelta Therapeutics; Gerson Lehrman Group; Novartis; WUGEN, Inc.
Research Funding - Kite, a Gilead company (Inst)
Patents, Royalties, Other Intellectual Property - CAR T Cells with Enhanced Metabolic Fitness. Serial Number: 62/939,727 (Inst); Double Mutant Survivin Vaccine. US010414810B2. (Inst); Evolutionary Dynamics of Non-Hodgkin Lymphoma CAR-T cell therapy. Serial Number: 62/879,534. (Inst); Methods of Enhancing CAR T Cell Therapies. Serial Number: 62/892,292. (Inst)
Travel, Accommodations, Expenses - Kite, a Gilead company
 
Patrick Michael Reagan
Consulting or Advisory Role - Curis; Kite, a Gilead company
Research Funding - Seagen
 
Caron A. Jacobson
Honoraria - Celgene; Humanigen; Kite/Gilead; Nkarta; Novartis; Precision Biosciences
Consulting or Advisory Role - Celgene; Humanigen; Kite/Gilead; Nkarta; Novartis; Pfizer; Precision Biosciences
Speakers' Bureau - Axis Pharma; Clinical Care Options/NCCN
Research Funding - Pfizer
Travel, Accommodations, Expenses - Celgene; Humanigen; Kite/Gilead; Novartis; Pfizer; Precision Biosciences
 
Brian T Hill
Honoraria - Abbvie; AstraZeneca; Bayer; Celgene; Genentech; Gilead Sciences; Novartis; Pfizer; Pharmacyclics; Seagen
Consulting or Advisory Role - Abbvie/Genentech; Novartis; Seagen
Research Funding - Abbvie (Inst); Amgen (Inst); Celgene (Inst); Genentech (Inst); Karyopharm Therapeutics (Inst); Kite/Gilead (Inst); Takeda (Inst)
 
Houston Holmes
Consulting or Advisory Role - AstraZeneca; Bayer; Celgene; Genentech; Kite/Gilead; Rigel
Speakers' Bureau - Dova Pharmaceuticals; Karyopharm Therapeutics; Kite, a Gilead company; Rigel; Seagen
Research Funding - Celgene (Inst); Genentech (Inst); Janssen (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst); Novartis (Inst); Unum Therapeutics (Inst)
Travel, Accommodations, Expenses - Celgene; Kite/Gilead; Rigel; Seagen
 
Samantha Mary Jaglowski
Consulting or Advisory Role - crispr therapeutics; Juno Therapeutics; Kite/Gilead; Novartis
Research Funding - Kite/Gilead; Novartis
 
Weimin Peng
Employment - Kite/Gilead
Stock and Other Ownership Interests - Gilead Sciences
 
Lianqing Zheng
Employment - Kite/Gilead
 
Xiang Fang
Employment - Kite/Gilead
Stock and Other Ownership Interests - Gilead Sciences
 
Allen Xue
Employment - Kite/Gilead
Stock and Other Ownership Interests - Gilead Sciences
 
Arati V. Rao
Employment - Kite/Gilead
 
Adrian Bot
Employment - Gilead Sciences; Kite/Gilead
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Gilead Sciences
Travel, Accommodations, Expenses - Gilead Sciences